Compile Data Set for Download or QSAR
Found 373 with Last Name = 'yamamoto' and Initial = 'a'
TargetTyrosine-protein kinase JAK1(Homo sapiens (Human))
Nissan Chemical Corporation

US Patent
LigandPNGBDBM411421(US10385052, Example 2)copy SMILES
Affinity DataIC50: 0.350nMAssay Description:The JAK inhibitory activities of compounds of the present invention were measured.The enzymes (JAK1, JAK2, JAK3 and Tyk2) were purchased from Carna B...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2154KC4US Patent
TargetTyrosine-protein kinase JAK1(Homo sapiens (Human))
Nissan Chemical Corporation

US Patent
LigandPNGBDBM254982(US9475813, 38)copy SMILES
Affinity DataIC50: 0.380nMAssay Description:The inhibitory activity of the compounds of the present invention against JAK was measured.The respective enzymes (JAK1, JAK2, JAK3 and Tyk2) were pu...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2PC31BNUS Patent
TargetTyrosine-protein kinase JAK1(Homo sapiens (Human))
Nissan Chemical Corporation

US Patent
LigandPNGBDBM411423(US10385052, Example 4)copy SMILES
Affinity DataIC50: 0.410nMAssay Description:The JAK inhibitory activities of compounds of the present invention were measured.The enzymes (JAK1, JAK2, JAK3 and Tyk2) were purchased from Carna B...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2154KC4US Patent
TargetTyrosine-protein kinase JAK1(Homo sapiens (Human))
Nissan Chemical Corporation

US Patent
LigandPNGBDBM254980(US9475813, 36)copy SMILES
Affinity DataIC50: 0.420nMAssay Description:The inhibitory activity of the compounds of the present invention against JAK was measured.The respective enzymes (JAK1, JAK2, JAK3 and Tyk2) were pu...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2PC31BNUS Patent
TargetTyrosine-protein kinase JAK1(Homo sapiens (Human))
Nissan Chemical Corporation

US Patent
LigandPNGBDBM411424(US10385052, Example 5)copy SMILES
Affinity DataIC50: 0.590nMAssay Description:The JAK inhibitory activities of compounds of the present invention were measured.The enzymes (JAK1, JAK2, JAK3 and Tyk2) were purchased from Carna B...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2154KC4US Patent
TargetTyrosine-protein kinase JAK2(Homo sapiens (Human))
Nissan Chemical Industries, Ltd.

US Patent
LigandPNGBDBM254982(US9475813, 38)copy SMILES
Affinity DataIC50: 0.620nMAssay Description:The inhibitory activity of the compounds of the present invention against JAK was measured.The respective enzymes (JAK1, JAK2, JAK3 and Tyk2) were pu...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2PC31BNUS Patent
TargetTyrosine-protein kinase JAK1(Homo sapiens (Human))
Nissan Chemical Corporation

US Patent
LigandPNGBDBM254981(US9475813, 37)copy SMILES
Affinity DataIC50: 0.650nMAssay Description:The inhibitory activity of the compounds of the present invention against JAK was measured.The respective enzymes (JAK1, JAK2, JAK3 and Tyk2) were pu...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2PC31BNUS Patent
TargetTyrosine-protein kinase JAK1(Homo sapiens (Human))
Nissan Chemical Corporation

US Patent
LigandPNGBDBM411425(US10385052, Example 6)copy SMILES
Affinity DataIC50: 0.680nMAssay Description:The JAK inhibitory activities of compounds of the present invention were measured.The enzymes (JAK1, JAK2, JAK3 and Tyk2) were purchased from Carna B...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2154KC4US Patent
TargetTyrosine-protein kinase JAK1(Homo sapiens (Human))
Nissan Chemical Corporation

US Patent
LigandPNGBDBM411426(US10385052, Example 7)copy SMILES
Affinity DataIC50: 0.740nMAssay Description:The JAK inhibitory activities of compounds of the present invention were measured.The enzymes (JAK1, JAK2, JAK3 and Tyk2) were purchased from Carna B...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2154KC4US Patent
TargetTyrosine-protein kinase JAK1(Homo sapiens (Human))
Nissan Chemical Corporation

US Patent
LigandPNGBDBM255032(US9475813, 53)copy SMILES
Affinity DataIC50: 0.850nMAssay Description:The inhibitory activity of the compounds of the present invention against JAK was measured.The respective enzymes (JAK1, JAK2, JAK3 and Tyk2) were pu...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2PC31BNUS Patent
TargetTyrosine-protein kinase JAK1(Homo sapiens (Human))
Nissan Chemical Corporation

US Patent
LigandPNGBDBM255001(US9475813, 6)copy SMILES
Affinity DataIC50: 0.880nMAssay Description:The inhibitory activity of the compounds of the present invention against JAK was measured.The respective enzymes (JAK1, JAK2, JAK3 and Tyk2) were pu...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2PC31BNUS Patent
TargetTyrosine-protein kinase JAK1(Homo sapiens (Human))
Nissan Chemical Corporation

US Patent
LigandPNGBDBM254979(US9475813, 2)copy SMILES
Affinity DataIC50: 0.880nMAssay Description:The inhibitory activity of the compounds of the present invention against JAK was measured.The respective enzymes (JAK1, JAK2, JAK3 and Tyk2) were pu...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2PC31BNUS Patent
TargetTyrosine-protein kinase JAK1(Homo sapiens (Human))
Nissan Chemical Corporation

US Patent
LigandPNGBDBM254995(US9475813, 51)copy SMILES
Affinity DataIC50: 0.900nMAssay Description:The inhibitory activity of the compounds of the present invention against JAK was measured.The respective enzymes (JAK1, JAK2, JAK3 and Tyk2) were pu...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2PC31BNUS Patent
TargetTyrosine-protein kinase JAK1(Homo sapiens (Human))
Nissan Chemical Corporation

US Patent
LigandPNGBDBM411420(US10385052, Example 1)copy SMILES
Affinity DataIC50: 0.990nMAssay Description:The JAK inhibitory activities of compounds of the present invention were measured.The enzymes (JAK1, JAK2, JAK3 and Tyk2) were purchased from Carna B...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2154KC4US Patent
TargetTyrosine-protein kinase JAK1(Homo sapiens (Human))
Nissan Chemical Corporation

US Patent
LigandPNGBDBM254988(US9475813, 44)copy SMILES
Affinity DataIC50: 1.40nMAssay Description:The inhibitory activity of the compounds of the present invention against JAK was measured.The respective enzymes (JAK1, JAK2, JAK3 and Tyk2) were pu...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2PC31BNUS Patent
TargetTyrosine-protein kinase JAK1(Homo sapiens (Human))
Nissan Chemical Corporation

US Patent
LigandPNGBDBM254996(US9475813, 66)copy SMILES
Affinity DataIC50: 1.40nMAssay Description:The inhibitory activity of the compounds of the present invention against JAK was measured.The respective enzymes (JAK1, JAK2, JAK3 and Tyk2) were pu...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2PC31BNUS Patent
TargetTyrosine-protein kinase JAK1(Homo sapiens (Human))
Nissan Chemical Corporation

US Patent
LigandPNGBDBM255010(US9475813, 15)copy SMILES
Affinity DataIC50: 1.40nMAssay Description:The inhibitory activity of the compounds of the present invention against JAK was measured.The respective enzymes (JAK1, JAK2, JAK3 and Tyk2) were pu...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2PC31BNUS Patent
TargetTyrosine-protein kinase JAK1(Homo sapiens (Human))
Nissan Chemical Corporation

US Patent
LigandPNGBDBM255002(US9475813, 7)copy SMILES
Affinity DataIC50: 1.40nMAssay Description:The inhibitory activity of the compounds of the present invention against JAK was measured.The respective enzymes (JAK1, JAK2, JAK3 and Tyk2) were pu...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2PC31BNUS Patent
TargetTyrosine-protein kinase JAK2(Homo sapiens (Human))
Nissan Chemical Industries, Ltd.

US Patent
LigandPNGBDBM411421(US10385052, Example 2)copy SMILES
Affinity DataIC50: 1.5nMAssay Description:The JAK inhibitory activities of compounds of the present invention were measured.The enzymes (JAK1, JAK2, JAK3 and Tyk2) were purchased from Carna B...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2154KC4US Patent
TargetTyrosine-protein kinase JAK1(Homo sapiens (Human))
Nissan Chemical Corporation

US Patent
LigandPNGBDBM254984(US9475813, 40)copy SMILES
Affinity DataIC50: 1.5nMAssay Description:The inhibitory activity of the compounds of the present invention against JAK was measured.The respective enzymes (JAK1, JAK2, JAK3 and Tyk2) were pu...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2PC31BNUS Patent
TargetTyrosine-protein kinase JAK2(Homo sapiens (Human))
Nissan Chemical Industries, Ltd.

US Patent
LigandPNGBDBM411425(US10385052, Example 6)copy SMILES
Affinity DataIC50: 1.60nMAssay Description:The JAK inhibitory activities of compounds of the present invention were measured.The enzymes (JAK1, JAK2, JAK3 and Tyk2) were purchased from Carna B...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2154KC4US Patent
TargetTyrosine-protein kinase JAK1(Homo sapiens (Human))
Nissan Chemical Corporation

US Patent
LigandPNGBDBM255034(US9475813, 55)copy SMILES
Affinity DataIC50: 1.60nMAssay Description:The inhibitory activity of the compounds of the present invention against JAK was measured.The respective enzymes (JAK1, JAK2, JAK3 and Tyk2) were pu...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2PC31BNUS Patent
TargetTyrosine-protein kinase JAK1(Homo sapiens (Human))
Nissan Chemical Corporation

US Patent
LigandPNGBDBM411422(US10385052, Example 3)copy SMILES
Affinity DataIC50: 1.70nMAssay Description:The JAK inhibitory activities of compounds of the present invention were measured.The enzymes (JAK1, JAK2, JAK3 and Tyk2) were purchased from Carna B...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2154KC4US Patent
TargetTyrosine-protein kinase JAK1(Homo sapiens (Human))
Nissan Chemical Corporation

US Patent
LigandPNGBDBM254987(US9475813, 43)copy SMILES
Affinity DataIC50: 1.80nMAssay Description:The inhibitory activity of the compounds of the present invention against JAK was measured.The respective enzymes (JAK1, JAK2, JAK3 and Tyk2) were pu...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2PC31BNUS Patent
TargetTyrosine-protein kinase JAK2(Homo sapiens (Human))
Nissan Chemical Industries, Ltd.

US Patent
LigandPNGBDBM254980(US9475813, 36)copy SMILES
Affinity DataIC50: 1.80nMAssay Description:The inhibitory activity of the compounds of the present invention against JAK was measured.The respective enzymes (JAK1, JAK2, JAK3 and Tyk2) were pu...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2PC31BNUS Patent
TargetTyrosine-protein kinase JAK2(Homo sapiens (Human))
Nissan Chemical Industries, Ltd.

US Patent
LigandPNGBDBM411423(US10385052, Example 4)copy SMILES
Affinity DataIC50: 1.90nMAssay Description:The JAK inhibitory activities of compounds of the present invention were measured.The enzymes (JAK1, JAK2, JAK3 and Tyk2) were purchased from Carna B...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2154KC4US Patent
TargetTyrosine-protein kinase JAK1(Homo sapiens (Human))
Nissan Chemical Corporation

US Patent
LigandPNGBDBM254990(US9475813, 46)copy SMILES
Affinity DataIC50: 1.90nMAssay Description:The inhibitory activity of the compounds of the present invention against JAK was measured.The respective enzymes (JAK1, JAK2, JAK3 and Tyk2) were pu...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2PC31BNUS Patent
TargetTyrosine-protein kinase JAK1(Homo sapiens (Human))
Nissan Chemical Corporation

US Patent
LigandPNGBDBM255038(US9475813, 59)copy SMILES
Affinity DataIC50: 1.90nMAssay Description:The inhibitory activity of the compounds of the present invention against JAK was measured.The respective enzymes (JAK1, JAK2, JAK3 and Tyk2) were pu...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2PC31BNUS Patent
TargetTyrosine-protein kinase JAK2(Homo sapiens (Human))
Nissan Chemical Industries, Ltd.

US Patent
LigandPNGBDBM255032(US9475813, 53)copy SMILES
Affinity DataIC50: 1.90nMAssay Description:The inhibitory activity of the compounds of the present invention against JAK was measured.The respective enzymes (JAK1, JAK2, JAK3 and Tyk2) were pu...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2PC31BNUS Patent
TargetTyrosine-protein kinase JAK1(Homo sapiens (Human))
Nissan Chemical Corporation

US Patent
LigandPNGBDBM255011(US9475813, 16)copy SMILES
Affinity DataIC50: 2nMAssay Description:The inhibitory activity of the compounds of the present invention against JAK was measured.The respective enzymes (JAK1, JAK2, JAK3 and Tyk2) were pu...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2PC31BNUS Patent
TargetTyrosine-protein kinase JAK1(Homo sapiens (Human))
Nissan Chemical Corporation

US Patent
LigandPNGBDBM255044(US9475813, 65)copy SMILES
Affinity DataIC50: 2nMAssay Description:The inhibitory activity of the compounds of the present invention against JAK was measured.The respective enzymes (JAK1, JAK2, JAK3 and Tyk2) were pu...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2PC31BNUS Patent
TargetTyrosine-protein kinase JAK2(Homo sapiens (Human))
Nissan Chemical Industries, Ltd.

US Patent
LigandPNGBDBM411424(US10385052, Example 5)copy SMILES
Affinity DataIC50: 2nMAssay Description:The JAK inhibitory activities of compounds of the present invention were measured.The enzymes (JAK1, JAK2, JAK3 and Tyk2) were purchased from Carna B...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2154KC4US Patent
TargetTyrosine-protein kinase JAK2(Homo sapiens (Human))
Nissan Chemical Industries, Ltd.

US Patent
LigandPNGBDBM411426(US10385052, Example 7)copy SMILES
Affinity DataIC50: 2nMAssay Description:The JAK inhibitory activities of compounds of the present invention were measured.The enzymes (JAK1, JAK2, JAK3 and Tyk2) were purchased from Carna B...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2154KC4US Patent
TargetTyrosine-protein kinase JAK1(Homo sapiens (Human))
Nissan Chemical Corporation

US Patent
LigandPNGBDBM255013(US9475813, 18)copy SMILES
Affinity DataIC50: 2nMAssay Description:The inhibitory activity of the compounds of the present invention against JAK was measured.The respective enzymes (JAK1, JAK2, JAK3 and Tyk2) were pu...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2PC31BNUS Patent
TargetTyrosine-protein kinase JAK1(Homo sapiens (Human))
Nissan Chemical Corporation

US Patent
LigandPNGBDBM254989(US9475813, 45)copy SMILES
Affinity DataIC50: 2.10nMAssay Description:The inhibitory activity of the compounds of the present invention against JAK was measured.The respective enzymes (JAK1, JAK2, JAK3 and Tyk2) were pu...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2PC31BNUS Patent
TargetTyrosine-protein kinase JAK2(Homo sapiens (Human))
Nissan Chemical Industries, Ltd.

US Patent
LigandPNGBDBM254979(US9475813, 2)copy SMILES
Affinity DataIC50: 2.10nMAssay Description:The inhibitory activity of the compounds of the present invention against JAK was measured.The respective enzymes (JAK1, JAK2, JAK3 and Tyk2) were pu...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2PC31BNUS Patent
TargetTyrosine-protein kinase JAK1(Homo sapiens (Human))
Nissan Chemical Corporation

US Patent
LigandPNGBDBM255007(US9475813, 12)copy SMILES
Affinity DataIC50: 2.20nMAssay Description:The inhibitory activity of the compounds of the present invention against JAK was measured.The respective enzymes (JAK1, JAK2, JAK3 and Tyk2) were pu...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2PC31BNUS Patent
TargetTyrosine-protein kinase JAK1(Homo sapiens (Human))
Nissan Chemical Corporation

US Patent
LigandPNGBDBM254986(US9475813, 42)copy SMILES
Affinity DataIC50: 2.20nMAssay Description:The inhibitory activity of the compounds of the present invention against JAK was measured.The respective enzymes (JAK1, JAK2, JAK3 and Tyk2) were pu...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2PC31BNUS Patent
TargetTyrosine-protein kinase JAK1(Homo sapiens (Human))
Nissan Chemical Corporation

US Patent
LigandPNGBDBM254999(US9475813, 4)copy SMILES
Affinity DataIC50: 2.40nMAssay Description:The inhibitory activity of the compounds of the present invention against JAK was measured.The respective enzymes (JAK1, JAK2, JAK3 and Tyk2) were pu...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2PC31BNUS Patent
TargetTyrosine-protein kinase JAK1(Homo sapiens (Human))
Nissan Chemical Corporation

US Patent
LigandPNGBDBM255023(US9475813, 28)copy SMILES
Affinity DataIC50: 2.40nMAssay Description:The inhibitory activity of the compounds of the present invention against JAK was measured.The respective enzymes (JAK1, JAK2, JAK3 and Tyk2) were pu...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2PC31BNUS Patent
TargetTyrosine-protein kinase JAK3(Homo sapiens (Human))
Nissan Chemical Corporation

US Patent
LigandPNGBDBM411425(US10385052, Example 6)copy SMILES
Affinity DataIC50: 2.5nMAssay Description:The JAK inhibitory activities of compounds of the present invention were measured.The enzymes (JAK1, JAK2, JAK3 and Tyk2) were purchased from Carna B...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2154KC4US Patent
TargetTyrosine-protein kinase JAK1(Homo sapiens (Human))
Nissan Chemical Corporation

US Patent
LigandPNGBDBM255014(US9475813, 19)copy SMILES
Affinity DataIC50: 2.60nMAssay Description:The inhibitory activity of the compounds of the present invention against JAK was measured.The respective enzymes (JAK1, JAK2, JAK3 and Tyk2) were pu...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2PC31BNUS Patent
TargetTyrosine-protein kinase JAK1(Homo sapiens (Human))
Nissan Chemical Corporation

US Patent
LigandPNGBDBM254997(US9475813, 67)copy SMILES
Affinity DataIC50: 2.60nMAssay Description:The inhibitory activity of the compounds of the present invention against JAK was measured.The respective enzymes (JAK1, JAK2, JAK3 and Tyk2) were pu...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2PC31BNUS Patent
TargetTyrosine-protein kinase JAK1(Homo sapiens (Human))
Nissan Chemical Corporation

US Patent
LigandPNGBDBM255039(US9475813, 60)copy SMILES
Affinity DataIC50: 2.70nMAssay Description:The inhibitory activity of the compounds of the present invention against JAK was measured.The respective enzymes (JAK1, JAK2, JAK3 and Tyk2) were pu...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2PC31BNUS Patent
TargetTyrosine-protein kinase JAK3(Homo sapiens (Human))
Nissan Chemical Corporation

US Patent
LigandPNGBDBM411424(US10385052, Example 5)copy SMILES
Affinity DataIC50: 2.70nMAssay Description:The JAK inhibitory activities of compounds of the present invention were measured.The enzymes (JAK1, JAK2, JAK3 and Tyk2) were purchased from Carna B...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2154KC4US Patent
TargetTyrosine-protein kinase JAK2(Homo sapiens (Human))
Nissan Chemical Industries, Ltd.

US Patent
LigandPNGBDBM254981(US9475813, 37)copy SMILES
Affinity DataIC50: 2.70nMAssay Description:The inhibitory activity of the compounds of the present invention against JAK was measured.The respective enzymes (JAK1, JAK2, JAK3 and Tyk2) were pu...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2PC31BNUS Patent
TargetTyrosine-protein kinase JAK3(Homo sapiens (Human))
Nissan Chemical Corporation

US Patent
LigandPNGBDBM411421(US10385052, Example 2)copy SMILES
Affinity DataIC50: 2.90nMAssay Description:The JAK inhibitory activities of compounds of the present invention were measured.The enzymes (JAK1, JAK2, JAK3 and Tyk2) were purchased from Carna B...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2154KC4US Patent
TargetTyrosine-protein kinase JAK1(Homo sapiens (Human))
Nissan Chemical Corporation

US Patent
LigandPNGBDBM255009(US9475813, 14)copy SMILES
Affinity DataIC50: 3nMAssay Description:The inhibitory activity of the compounds of the present invention against JAK was measured.The respective enzymes (JAK1, JAK2, JAK3 and Tyk2) were pu...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2PC31BNUS Patent
TargetTyrosine-protein kinase JAK2(Homo sapiens (Human))
Nissan Chemical Industries, Ltd.

US Patent
LigandPNGBDBM254984(US9475813, 40)copy SMILES
Affinity DataIC50: 3.10nMAssay Description:The inhibitory activity of the compounds of the present invention against JAK was measured.The respective enzymes (JAK1, JAK2, JAK3 and Tyk2) were pu...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2PC31BNUS Patent
TargetTyrosine-protein kinase JAK1(Homo sapiens (Human))
Nissan Chemical Corporation

US Patent
LigandPNGBDBM255017(US9475813, 22)copy SMILES
Affinity DataIC50: 3.20nMAssay Description:The inhibitory activity of the compounds of the present invention against JAK was measured.The respective enzymes (JAK1, JAK2, JAK3 and Tyk2) were pu...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2PC31BNUS Patent
Displayed 1 to 50 (of 373 total ) | Next | Last >>
Jump to: